A. Alpha adrenergic blockers (alfuzosin, doxazosin, silodosin, tamsulosin, and terazosin) B. Hormonal manipulation (including finasteride, dutasteride, and dutasteride plus tamsulosin) C. Interstitial laser coagulation of the prostate (ILCP) D. Laser prostatectomy E. Laser based procedures including contact laser ablation of the prostate (CLAP), holmium laser procedures of the prostate (HoLAP, ...

Hypothesis / aims of study Currently, the α1-adrenoceptor (α1-AR) antagonist/antimuscarinic combination appears to be a second-line add-on for patients with insufficient symptom relief after monotherapy in males with LUTS associated with bladder outlet obstruction (BOO) (1). However, no urodynamic evaluation has been reported on the effect of the combination therapy. In this study, first, by us...

Hypothesis / aims of study Alpha-1 blockers are the first option for the medical treatment of benign prostatic hyperplasia (BPH), and differ in their likelihood of causing abnormal ejaculation and sexual dysfunction, depending on their affinity of alpha-1 adrenoceptor subtypes. A new alpha-1 blocker, silodosin is 162 times more selective for alpha-1A than for alpha-1B, and is approximately 55 t...

A. Alpha adrenergic blockers (alfuzosin, doxazosin, silodosin, tamsulosin, and terazosin) B. Hormonal manipulation (including finasteride, dutasteride, and dutasteride plus tamsulosin) C. Interstitial laser coagulation of the prostate (ILCP) D. Laser prostatectomy E. Laser based procedures including contact laser ablation of the prostate (CLAP), holmium laser procedures of the prostate (HoLAP, ...

Abstract Introduction Dhat Syndrome, a syndrome which has obtained the status of culture-bound sexual neurosis, is difficult to treat due unwavering belief patient that his symptoms are attributable semen loss. At present, treatment aimed at relieving anxiety and depression associated with this condition not addressal root cause. The best way address by direct demonstration prevention ejaculati...

Background Information: Currently alpha1-adrenoreceptor blockers with the combination of 5- alpha reductase inhibitors are widely used as first-line therapy to improve Lower urinary tract symptoms (LUTS) associated Benign Prostatic Hyperplasia (BPH). Aims And Objectives:The aim this study was evaluate Efficacy drug Silodosin and Dutasteride in patients mild severe symptoms. Materials Methods:Th...